Health Minister Dr. Nalinda Jayatissa has raised serious concerns over what he described as sensationalist and misleading media reports on medicine shortages in Sri Lanka, suggesting that some narratives may be intended to justify overpriced emergency procurements rather than reflect genuine concern for patients.
Speaking at the Cabinet media briefing on April 29, the Minister acknowledged that supply chain disruptions exist but firmly denied accusations of systemic failure. He pointed to a recent insulin supply issue, explaining that the problem arose not from a procurement failure but due to a delay by the supplier in delivering the required quantity. This situation led to a temporary adjustment in dosage for some patients. However, he stressed that the matter was being swiftly addressed. On April 12, the country imported enough insulin to last three and a half months, and another shipment sufficient for two more months is expected within the next two weeks.
Dr. Jayatissa elaborated on the complexities of the procurement process, noting that from initiating a tender to receiving delivery, the process could take up to seven months. In the meantime, the Ministry is working to secure emergency medical supplies through bilateral agreements with seven countries. He clarified that direct imports from abroad only occur when local suppliers fail to fulfill their obligations and that diplomatic interventions are necessary under such circumstances to ensure continued public access to essential medicines.
The Minister also stated that efforts are ongoing to maintain a buffer stock of essential medicines sufficient for three to six months. He issued a clear warning to local suppliers against attempting to manipulate the pharmaceutical market for personal gain, saying that any supplier unable to deliver on time risks having their NMRA registration reviewed. He stressed that this is a national issue and called for accountability and responsibility from all parties involved.
Furthermore, Dr. Jayatissa addressed public perceptions around availability, clarifying that the presence or absence of a drug at the Medical Supplies Division (MSD) alone should not be taken as an indication of a nationwide shortage. He emphasized that supplies may still be available in regional warehouses or hospitals and urged a more holistic view when assessing the national stock levels.
The Minister called on media outlets to report responsibly and reminded all stakeholders that ensuring consistent access to medication is a shared duty that must remain above political or commercial interests.
